NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,127 filers reported holding NOVARTIS A G in Q2 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $708,436 | +4.1% | 6,955 | +3.1% | 0.19% | +3.2% |
| Q2 2023 | $680,436 | -2.3% | 6,743 | -10.9% | 0.18% | -5.1% |
| Q1 2023 | $696,624 | +8.3% | 7,572 | +6.8% | 0.20% | +2.1% |
| Q4 2022 | $643,477 | +135.7% | 7,093 | +97.2% | 0.19% | +112.2% |
| Q3 2022 | $273,000 | -11.4% | 3,597 | -1.2% | 0.09% | -10.9% |
| Q2 2022 | $308,000 | -15.2% | 3,640 | -12.0% | 0.10% | -10.6% |
| Q1 2022 | $363,000 | +6.1% | 4,136 | +5.0% | 0.11% | -0.9% |
| Q4 2021 | $342,000 | +25.7% | 3,939 | +18.4% | 0.11% | +14.0% |
| Q3 2021 | $272,000 | -0.7% | 3,326 | +10.7% | 0.10% | -9.1% |
| Q2 2021 | $274,000 | +10.0% | 3,005 | +3.0% | 0.11% | -5.2% |
| Q1 2021 | $249,000 | -0.8% | 2,917 | +9.9% | 0.12% | -6.5% |
| Q4 2020 | $251,000 | +17.3% | 2,655 | +7.9% | 0.12% | -0.8% |
| Q3 2020 | $214,000 | -0.5% | 2,461 | 0.0% | 0.12% | -6.0% |
| Q2 2020 | $215,000 | – | 2,461 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PRENTISS SMITH & CO INC | 127,510 | $11,721,000 | 6.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 127,716 | $11,740,000 | 6.04% |
| EXENCIAL WEALTH ADVISORS, LLC | 116,917 | $10,747,000 | 5.25% |
| MCDANIEL TERRY & CO | 181,095 | $16,646,000 | 4.64% |
| Fayerweather Charles | 18,180 | $1,671,000 | 4.54% |
| Osher Van de Voorde Investment Management | 78,138 | $7,182,000 | 4.38% |
| BROWN BROTHERS HARRIMAN & CO | 9,291,495 | $854,074,000 | 4.35% |
| Boulegeris Investments, Inc. | 61,322 | $5,637,000 | 4.31% |
| DODGE & COX | 45,723,035 | $4,202,861,000 | 4.23% |
| WHV Investments, Inc. | 1,603,476 | $152,945,000 | 4.23% |